DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
Clinical trial NCT06329908 · RECRUITING
Trial details
- NCT number
- NCT06329908
- Sponsor
- Zhen-Yu Ding
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.